Ribeiro Ramiro

Chief Medical Officer

Ribeiro Ramiro has filed 7 SEC Form 4 filings (15 transaction rows) across 1 company, with disclosures dating back to 2025. 7 of those filings fall inside the rolling window. Most recent filing: Jul 2, 2026.

On the most recent filing, Ribeiro Ramiro is listed as Chief Medical Officer at EyePoint, Inc. Inside the rolling window, Ribeiro Ramiro reported no open-market purchases and 6 open-market sales totaling $949K in EYPT. The largest disclosed transaction in the window is a sale of 42,544 EYPT shares on Jan 5, 2026, worth $727K.

Companies traded

Other insiders at EYPT

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$949K

reported sales (SEC code S)

Companies

1

in the rolling window

Source
EYPTSale$73KJul 2SEC ↗
EYPTSale$37KApr 20SEC ↗
EYPTSale$44KMar 5SEC ↗
EYPTSale$37KFeb 18SEC ↗
EYPTSale$727KJan 7SEC ↗
EYPTSale$32KNov 12SEC ↗
Showing 1–6 of 6
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Ribeiro Ramiro made?

Ribeiro Ramiro has filed 7 SEC Form 4 filings (15 transaction rows) across 1 company since 2025.

Which companies does Ribeiro Ramiro trade?

Ribeiro Ramiro has filed SEC Form 4 disclosures for 1 company, including EYPT.

When was Ribeiro Ramiro's most recent SEC Form 4 filing?

Ribeiro Ramiro's most recent SEC Form 4 filing on Tracefour is dated Jul 2, 2026.

What is Ribeiro Ramiro's job title?

On the most recent SEC Form 4 filings tracked by Tracefour, Ribeiro Ramiro is listed as Chief Medical Officer.

What is Ribeiro Ramiro's total buy and sell value in the current window?

Inside the rolling retention window, Ribeiro Ramiro bought $0 and sold $949K based on SEC Form 4 filings.

What was Ribeiro Ramiro's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 42,544 EYPT shares on 2026-01-05, worth $727K, per SEC Form 4 filings.